Market Insider

Amazon.com delivery trucks in Richmond, California, U.S., on Tuesday, Oct. 13, 2020.
David Paul Morris | Bloomberg | Getty Images

Check out the companies making headlines in extended trading.

Amazon — Shares of the e-commerce giant plunged as much as about 19% in extended trading Thursday after the company posted weaker-than-expected earnings and revenue for the third quarter and issued disappointing fourth-quarter sales guidance.

Apple — Apple share fell as much as about 4% following its quarterly financial report, which included weaker-than-expected iPhone revenue. Apple still beat Wall Street estimates for its earnings and revenue, however, and the shares pared their losses.

Intel — The chipmaker saw shares gain 7.5% after it said it will deliver up to $10 billion in cost reductions and efficiency improvements through 2025. The announcement came as part of its financial results for the most recent quarter.

Pinterest — The social media platform’s shares climbed 15% postmarket after it third-quarter earnings and revenue both topped estimates. Pinterest said operating expenses should grow about 35% year-over-year for 2022.

Gilead Sciences — The pharma company added about 4% after third-quarter earnings beat analyst estimates, according to FactSet. Gilead also posted better-than-expected revenue and issued upbeat earnings and total product sales guidance.

Vertex Pharmaceuticals — Shares of the biotech company gained 3% following strong quarterly financial results. Earnings and revenue for the third quarter beat analysts’ estimates, according to FactSet. Vertex also raised its revenue guidance for the year.

Capital One — The bank’s shares fell 6% in extended trading after Capital One’s third quarter earnings missed analysts’ average per-share estimates by about 18%. Capital One earned $4.20 per share, while analysts were looking for $5.11, according to FactSet.

Articles You May Like

The One Way to Get in on Elon Musk’s Robotaxi Before Its 10/10 Debut
3 More Stocks Billionaires Are Buying Now
Recursion gets FDA approval to begin phase 1 trials of AI-discovered cancer treatment
China stocks just had their best day in 16 years, sending related U.S. ETFs soaring
Charles Schwab CEO Walt Bettinger to retire at end of 2024, Rick Wurster to replace him